The nicotine metabolite, cotinine, attenuates glutamate (NMDA) antagonist-related effects on the performance of the five choice serial reaction time task (5C-SRTT) in rats

Biochemical Pharmacology

Volumn 83, Issue 7, 2012, Pages 941-951

  Terry Jr , Alvin V ^a   Buccafusco, Jerry J ^a   Schade, R Foster ^a   Vandenhuerk, Leah ^a   Callahan, Patrick M ^a   Beck, Wayne D ^a   Hutchings, Elizabeth J ^a   Chapman, James M ^b   Li, Pei ^c   Bartlett, Michael G ^c  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b University of South Carolina   (United States)

^c UNIVERSITY OF GEORGIA   (United States)

Author keywords

Attention; Compulsivity; Impulsivity; Nicotinic; Schizophrenia

Indexed keywords

COTININE; DIZOCILPINE; GLUTAMATE RECEPTOR;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENTION; COMPULSION; CONTROLLED STUDY; IMPULSIVENESS; MALE; MENTAL PERFORMANCE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPONSE TIME;

ANIMALS; BEHAVIOR, ANIMAL; BRAIN; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; COTININE; DIZOCILPINE MALEATE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG STABILITY; MALE; N-METHYLASPARTATE; NICOTINE; PSYCHOMOTOR PERFORMANCE; RATS; RATS, WISTAR; REACTION TIME; TANDEM MASS SPECTROMETRY; TISSUE DISTRIBUTION;

EID: 84857361348     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2011.12.043     Document Type: Article

References (61)

1. N.L. Benowitz, F. Kuyt, and P. Jacob 3rd Circadian blood nicotine concentrations during cigarette smoking Clin Pharmacol Ther 32 Dec (6) 1982 758 764
2. C. Feyerabend, R.M. Ings, and M.A. Russel Nicotine pharmacokinetics and its application to intake from smoking Br J Clin Pharmacol 19 February (2) 1985 239 247
3. M.J. Jarvis, M.A. Russell, N.L. Benowitz, and C. Feyerabend Elimination of cotinine from body fluids: implications for noninvasive measurement of tobacco smoke exposure Am J Public Health 78 June (6) 1988 696 698
4. N.L. Benowitz, and P. Jacob 3rd Metabolism of nicotine to cotinine studied by a dual stable isotope method Clin Pharmacol Ther 56 November (5) 1994 483 493
5. N.L. Benowitz Cotinine as a biomarker of environmental tobacco smoke exposure Epidemiol Rev 18 2 1996 188 204
6. J. Hukkanen, P. Jacob IIIrd, and N.L. Benowitz Metabolism and disposition kinetics of nicotine Pharmacol Rev 57 March (1) 2005 79 115
7. J.F. Borzelleca, E.R. Bowman, and H. McKennis Jr. Studies on the respiratory and cardiovascular effects of (-)-cotinine J Pharmacol Exp Ther 137 September 1962 313 318
8. K.I. Yamamoto, and E.F. Domino Nicotine-induced EEG and behavioral arousal Int J Neuropharmacol 4 November (6) 1965 359 373
9. J.A. Rosecrans Nicotine as a discriminative stimulus to behavior: its characterization and relevance to smoking behavior NIDA Res Monogr January (23) 1979 58 69
10. L.G. Abood, D.T. Reynolds, H. Booth, and J.M. Bidlack Sites and mechanisms for nicotine's action in the brain Neurosci Biobehav Rev 5 Winter (4) 1981 479 486
11. J.W. Sloan, G.D. Todd, and W.R. Martin Nature of nicotine binding to rat brain P2 fraction Pharmacol Biochem Behav 20 June (6) 1984 899 909
12. 3H] methylcarbamylcholine in rat brain Eur J Pharmacol 253 March (3) 1994 261 267
13. P.J. Vainio, and R.K. Tuominen Cotinine binding to nicotinic acetylcholine receptors in bovine chromaffin cell and rat brain membranes Nicotine Tob Res 3 May (2) 2001 177 182
14. 3H]dopamine release from rat striatal slices in a calcium-dependent manner J Pharmacol Exp Ther 288 1999 905 911
15. J.J. Buccafusco, and A.V. Terry Jr. The potential role of cotinine in the cognitive and neuroprotective actions of nicotine Life Sci 72 May (26) 2003 2931 2942
16. E.D. Srivastava, M.B. Hallett, and J. Rhodes Effect of nicotine and cotinine on the production of oxygen free radicals by neutrophils in smokers and non-smokers Hum Toxicol 8 November (6) 1989 461 463
17. K. Rehani, D.A. Scott, D. Renaud, H. Hamza, L.R. Williams, and H. Wang Cotinine-induced convergence of the cholinergic and PI3 kinase-dependent anti-inflammatory pathways in innate immune cells Biochim Biophys Acta 1783 March (3) 2008 375 382
18. K.T. O'Leary, S.E. Loughlin, Y. Chen, and F.M. Leslie Nicotinic acetylcholine receptor subunit mRNA expression in adult and developing rat medullary catecholamine neurons J Comp Neurol 510 October (6) 2008 655 672
19. V. Echeverria, R. Zeitlin, S. Burgess, S. Patel, A. Barman, and G. Thakur Cotinine reduces amyloid-β aggregation and improves memory in Alzheimer's disease mice J Alzheimers Dis 24 January (4) 2011 817 835
20. J.J. Buccafusco, and W.J. Jackson Beneficial effects of nicotine administered prior to a delayed matching-to-sample task in young and aged monkeys Neurobiol Aging 12 May-June (3) 1991 233 238
21. A.V. Terry Jr., J.J. Buccafusco, and W.J. Jackson Scopolamine reversal of nicotine enhanced delayed matching-to-sample performance in monkeys Pharmacol Biochem Behav 45 August 4 1993 925 929
22. A.V. Terry Jr., C.M. Hernandez, E.J. Hohnadel, K.P. Bouchard, and J.J. Buccafusco Cotinine, a neuroactive metabolite of nicotine: potential for treating disorders of impaired cognition CNS Drug Rev 11 Autumn (3) 2005 229 252
23. J.J. Buccafusco, and A.V. Terry Jr. A reversible model of the cognitive impairment associated with schizophrenia in monkeys: potential therapeutic effects of two nicotinic acetylcholine receptor agonists Biochem Pharmacol 78 2009 852 862
24. D.K. Hatsukami, M. Grillo, P.R. Pentel, C. Oncken, and R. Bliss Safety of cotinine in humans: physiologic, subjective, and cognitive effects Pharmacol Biochem Behav 57 August (4) 1997 643 650
25. M.L. Middlemore-Risher, J.J. Buccafusco, and A.V. Terry Jr. Repeated exposures to low-level chlorpyrifos results in impairments in sustained attention and increased impulsivity in rats Neurotoxicol Teratol 32 2010 415 424
26. J.P. Rung, A. Carlsson, K. Rydén Markinhuhta, and M.L. Carlsson (+)-MK-801 induced social withdrawal in rats; a model for negative symptoms of schizophrenia Prog Neuropsychopharmacol Biol Psychiatry 29 5 2005 827 832
27. N. Amitai, and A. Markou Disruption of performance in the five-choice serial reaction time task induced by administration of N-methyl-d-aspartate receptor antagonists: relevance to cognitive dysfunction in schizophrenia Biol Psychiatry 68 July (1) 2010 5 16
28. G. Tsai, and J.T. Coyle Glutamatergic mechanisms in schizophrenia Annu Rev Pharmacol Toxicol 42 2002 165 179
29. K.H. Nuechlerlein, and M. Dawson Information processing and attentional functioning in the developmental course of schizophrenic disorders Schizophr Bull 10 1984 160 203
30. B.A. Cornblatt, and J.G. Kielp Impaired attention, genetics, and the pathophysiology of schizophrenia Schizophr Bull 20 1994 3l 46l
31. T.W. Robbins The 5-choice serial reaction time task: behavioural pharmacology and functional neurochemistry Psychopharmacology (Berl) 163 2002 362 380
32. H.E. Rosvold, A.F. Mirsky, I. Sarason, E.D. Bransome Jr., and L.H. Beck A Continuous Performance Test of brain damage J Consult Psychol 20 1956 343 350
33. M. Carli, and R. Samanin Serotonin2 receptor agonists and serotonergic anorectic drugs affect rats' performance differently in a five-choice serial reaction time task Psychopharmacology (Berl) 106 2 1992 228 234
34. C. Mirjana, M. Baviera, R.W. Invernizzi, and C. Balducci The serotonin 5-HT2A receptors antagonist M100907 prevents impairment in attentional performance by NMDA receptor blockade in the rat prefrontal cortex Neuropsychopharmacology 29 September (9) 2004 1637 1647
35. V. Kumari, and P. Postma Nicotine use in schizophrenia: the self medication hypotheses Neurosci Biobehav Rev 29 6 2005 1021 1034
36. S. Leonard, S. Mexal, and R. Freedman Smoking, genetics and schizophrenia: evidence for self medication J Dual Diagn 3 November (3-4) 2007 43 59
37. M.S. D'Souza, and A. Markou Schizophrenia and tobacco smoking comorbidity: nAChR agonists in the treatment of schizophrenia-associated cognitive deficits Neuropharmacology February 2011 [PMID: 21288470], http://dx.doi.org/10.1016/j.neuropharm.2011.01.044
38. C.A. Briggs, and D.G. McKenna Activation and inhibition of the human alpha7 nicotinic acetylcholine receptor by agonists Neuropharmacology 37 September (9) 1998 1095 1102
39. C.A. Briggs, and D.G. McKenna Effect of MK-801 at the human alpha 7 nicotinic acetylcholine receptor Neuropharmacology 35 April (4) 1996 407 414
40. M. Alkondon, E.S. Rocha, A. Maelicke, and E.X. Albuquerque Diversity of nicotinic acetylcholine receptors in rat brain. V. alpha-Bungarotoxin-sensitive nicotinic receptors in olfactory bulb neurons and presynaptic modulation of glutamate release J Pharmacol Exp Ther 278 September (3) 1996 1460 1471
41. R. Girod, N. Barazangi, D. McGehee, and L.W. Role Facilitation of glutamatergic neurotransmission by presynaptic nicotinic acetylcholine receptors Neuropharmacology 39 October (13) 2000 2715 2725
42. R. Gray, A.S. Rajan, K.A. Radcliffe, M. Yakehiro, and J.A. Dani Hippocampal synaptic transmission enhanced by low concentrations of nicotine Nature 383 October (6602) 1996 713 716
43. D. Ji, R. Lape, and J.A. Dani Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity Neuron 31 July (1) 2001 131 141
44. H.D. Mansvelder, and D.S. McGehee Long-term potentiation of excitatory inputs to brain reward areas by nicotine Neuron 27 August (2) 2000 349 357
45. H.D. Mansvelder, J.R. Keath, and D.S. McGehee Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas Neuron 33 March (6) 2002 905 919
46. D.S. McGehee, M.J. Heath, S. Gelber, P. Devay, and L.W. Role Nicotine enhancement of fast excitatory synaptic transmission in CNS by presynaptic receptors Science 269 September (5231) 1995 1692 1696
47. V.B. Aramakis, and R. Metherate Nicotine selectively enhances NMDA receptor-mediated synaptic transmission during postnatal development in sensory neocortex J Neurosci 18 October (20) 1998 8485 8495
48. M.D. Santos, M. Alkondon, E.F. Pereira, Y. Aracava, H.M. Eisenberg, and A. Maelicke The nicotinic allosteric potentiating ligand galantamine facilitates synaptic transmission in the mammalian central nervous system Mol Pharmacol 61 May (5) 2002 1222 1234
49. A.H. Rezvani, M. Cauley, H. Sexton, Y. Xiao, M.L. Brown, and M.A. Paige Sazetidine-A, a selective α4β2 nicotinic acetylcholine receptor ligand: effects on dizocilpine and scopolamine-induced attentional impairments in female Sprague-Dawley rats Psychopharmacology (Berl) 215 June (4) 2011 621 630
50. M.R. Picciotto, N.A. Addy, Y.S. Mineur, and D.H. Brunzell It is not either/or: activation and desensitization of nicotinic acetylcholine receptors both contribute to behaviors related to nicotine addiction and mood Prog Neurobiol 84 April (4) 2008 329 342
51. J.J. Buccafusco, J.W. Beach, and A.V. Terry Jr. Desensitization of nicotinic acetylcholine receptors as a strategy for drug development J Pharmacol Exp Ther 328 February (2) 2009 364 370
52. J.M. Williams, D.M. Ziedonis, F. Abanyie, M.L. Steinberg, J. Foulds, and N.L. Benowitz Increased nicotine and cotinine levels in smokers with schizophrenia and schizoaffective disorder is not a metabolic effect Schizophr Res 79 November (2-3) 2005 323 335
53. C. Halldin, K. Ngren, C.G. Swahn, B. Lngström, and H. Nybäck (S)- and (R)-[11C]nicotine and the metabolite (R/S)-[11C]cotinine, Preparation, metabolite studies and in vivo distribution in the human brain using PET Int J Rad Appl Instrum B 19 November (8) 1992 871 880
54. G.W. Paulson, and B.L. Olson Can smoking be detected from cerebrospinal fluid? Clin Neuropharmacol 18 August (4) 1995 375 376
55. P.A. Crooks, M. Li, and L.P. Dwoskin Metabolites of nicotine in rat brain after peripheral nicotine administration. Cotinine, nornicotine, and norcotinine. Drug Metab Dispos. 1997 Jan;25(1):47-54 Clin Neuropharmacol 25 January (1) 1997 47 54
56. E. Hansson, and C.G. Schmitterlöw Metabolism of nicotin in various tissues U.S. von Euler, Tobacco alkaloids and related compounds 1965 Pergamon Press Oxford 87 97
57. O. Riah, P. Courrire, J.C. Dousset, N. Todeschi, and C. Labat Nicotine is more efficient than cotinine at passing the blood-brain barrier in rats Cell Mol Neurobiol 18 June (3) 1998 311 318
58. C. Reavill, B. Walther, I.P. Stolerman, and B. Testa Behavioural and pharmacokinetic studies on nicotine, cytisine and lobeline Neuropharmacology 29 July (7) 1990 619 624
59. K.E. Herzig, E. Callaway, R. Halliday, H. Naylor, and N.L. Benowitz Effects of cotinine on information processing in nonsmokers Psychopharmacology (Berl) 135 January (2) 1998 127 132
60. E.R. Marcotte, D.M. Pearson, and L.K. Srivastava Animal models of schizophrenia: a critical review J Psychiatry Neurosci 26 November (5) 2001 395 410
61. M.W. Decker Cognition models and drug discovery E.D. Levin, J.J. Buccafusco, Animal models of cognitive impairment 2006 CRC Press Boca Raton [chapter 16]